UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Korean drugmakers promote pipelines at JP Morgan event
Korean pharmaceutical and biotech firms publicized their competitiveness, u...
by So Jae-hyeon
|
2018-01-11 15:42
라인
Drugmakers speed up ownership successions
Since the beginning of the New Year, pharmaceutical companies are accelerat...
by So Jae-hyeon
|
2018-01-11 12:01
라인
Drugmakers play it safe under ‘K-Sunshine Act’
Drugmakers are limiting salespersons’ use of corporate credit cards amid co...
by So Jae-hyeon
|
2018-01-10 14:23
라인
Leukemia drug faces longer PMS on demand shortage
Il-yang Pharm’s new leukemia treatment Supect (ingredient: radotinib) will ...
by So Jae-hyeon
|
2018-01-09 11:44
라인
Drugmakers rush to attend JP Morgan’s healthcare event
Many local pharmaceutical and biotech companies plan to attend J.P. Morgan’...
by So Jae-hyeon
|
2018-01-08 11:44
라인
Working style of drug salespersons changed by tougher rules
In recent years, South Korea has adopted a series of regulations and laws t...
by So Jae-hyeon
|
2018-01-05 16:03
라인
Anticoagulant latecomer Lixiana outperforms Pradaxa
The market of non-vitamin K antagonist oral anticoagulants (NOACs), which r...
by So Jae-hyeon
|
2018-01-03 10:56
라인
HanAll vice chairman sells off stake despite export deal
HanAll Biopharma Vice Chairman Kim Sung-wuk unexpectedly sold off part of h...
by So Jae-hyeon
|
2018-01-02 13:57
라인
HanAll inks $30 million tech export deal
HanAll Biopharma said it signed a $30 million deal with a U.S. company to t...
by So Jae-hyeon
|
2017-12-20 15:49
라인
Korean drugmakers import from UK, export to Japan the most
South Korean pharmaceutical companies’ largest export destination of raw ma...
by So Jae-hyeon
|
2017-12-19 14:54
라인
Pharmacists protest convenience stores’ OTC drug sales
The Korean Pharmaceutical Association (KPA), a group of local pharmacists, ...
by So Jae-hyeon
|
2017-12-18 15:05
라인
Medytox, Hugel compete in botulinum toxin market
Medytox and Hugel have achieved a rapid growth in manufacturing botulinum t...
by So Jae-hyeon
|
2017-12-15 15:12
라인
Parkinson’s disease treatment Azilect in robust growth
Lundbeck Korea’s Azilect (ingredient: rasagiline) is performing well in Kor...
by So Jae-hyeon
|
2017-12-15 11:36
라인
‘New cancer drugs need 601 days to get insurance in Korea’
Newly approved cancer drugs need at least 601 days to receive insurance ben...
by So Jae-hyeon
|
2017-12-14 11:27
라인
Daewoong’s liver drug Ursa to enter US market
Daewoong Pharmaceutical said it aimed to sell its flagship product Ursa, a ...
by So Jae-hyeon
|
2017-12-13 15:23
라인
Wholesalers sweat over drug companies’ forceful sales
Local wholesalers of pharmaceutical products are experiencing distress at t...
by So Jae-hyeon
|
2017-12-13 11:33
라인
Drugmakers lead job growth in manufacturing sector
The pharmaceutical industry has led the growth of jobs in the manufacturing...
by So Jae-hyeon
|
2017-12-12 15:12
라인
Pfizer pays most to doctors for overseas academic events
Among multinational pharmaceutical companies, Pfizer Korea paid the largest...
by So Jae-hyeon
|
2017-12-11 16:28
라인
Local novel drugs achieve rapid growth in Q3
Novel drugs by local drugmakers achieved a rapid sales growth in the third ...
by So Jae-hyeon
|
2017-12-07 11:53
라인
Industry groups to support AI-based new drugs
The Korea Pharmaceutical and Bio-pharma Manufacturers’ Association (KPBMA) ...
by So Jae-hyeon
|
2017-12-05 16:13
-
1
2
3
4
5
6
7
8
9
10
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top